Pandemic (H1N1) 2009 influenza virus seroconversion rates in HIV-infected individuals

Journal of Acquired Immune Deficiency Syndromes

Volumn 56, Issue 2, 2011, Pages 91-94

  Kok, Jen ^a   Tudo, Katherine ^a   Blyth, Christopher C ^b   Foo, Hong ^c   Hueston, Linda ^a   Dwyer, Dominic E ^a  

^a WESTMEAD HOSPITAL   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c WOLLONGONG HOSPITAL   (Australia)

Author keywords

H1N1; HIV; influenza; pandemic; vaccination

Indexed keywords

ANTIBODY; INFLUENZA VACCINE;

2009 H1N1 INFLUENZA; ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; AUSTRALIA; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE SEVERITY; FEMALE; HIGH RISK POPULATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOSUPPRESSIVE TREATMENT; INFLUENZA A (H1N1); INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; MALE; PANDEMIC INFLUENZA; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SEROCONVERSION; SEROPREVALENCE; VIRUS LOAD; WINTER;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, VIRAL; CD4 LYMPHOCYTE COUNT; FEMALE; HIV; HIV INFECTIONS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MALE; MIDDLE AGED; NEW SOUTH WALES; SEROEPIDEMIOLOGIC STUDIES; VIRAL LOAD; YOUNG ADULT;

EID: 78751612606     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/QAI.0b013e318204a1c3     Document Type: Article

References (23)

1. The ANZIC Influenza Investigators. Critical care services and 2009 H1N1 influenza in Australia and New Zealand. N Engl J Med. 2009;361: 1925-1934.
2. Centers for Disease Control and Prevention (CDC). Hospitalized patients with novel influenza A (H1N1) virus infection-California, April-May, 2009. MMWR Morb Mortal Wkly Rep. 2009;58:536-541.
3. Writing Committee of the WHO Consultation on Clinical Aspects of Pandemic (H1N1) 2009 Influenza. Clinical aspects of pandemic (H1N1) 2009 influenza infection. N Engl J Med. 2010;362:1708-1719.
4. Archer BN, Cohen C, Naidoo D, et al. Interim report on pandemic H1N1 influenza virus infections in South Africa, April to October 2009: epidemiology and factors associated with fatal cases. Euro Surveill. 2009;14: pii 19369. Available at: http://www.eurosurveillance.org/ViewArticle.aspx? ArticleId=19369. Accessed June 21, 2010.
5. Klein NC, Chak A, Chengot M, et al. Fatal case of pneumonia associated with pandemic (H1N1) 2009 in HIV-positive patient. Emerg Infect Dis. 2010;16:149-150.
6. Isais F, Lye D, Llorin R, et al. Pandemic (H1N1) 2009 influenza in HIV-infected adults: clinical features, severity, and outcome. J Infect. 2010; doi:10.1016/j.jinf.2010.08.002.
7. Campos-Loza A, Soto-Raḿrez L, Sierra-Madero J, et al. New swine-origin influenza A (H1N1)v in HIV-infected patients during the 2009 outbreak in Mexico City. 801. Presented at: 17th Conference on Retroviruses and Opportunistic Infections; 2010; San Francisco, CA.
8. Webster R, Cox N, Stöhr K. WHO manual on animal influenza diagnosis and surveillance 2002. Available at: http://www.who.int/vaccine-research/ diseases/influenza/WHO-manual-on-animal-diagnosis-and-surveillance-2002-5.pdf. Accessed April 9, 2010.
9. Australian Government Department of Health and Ageing. Australian Influenza Surveillance Summary Report No. 31, 2009, Reporting Period: 5 December 2009-11 December 2009. Available at: http://www.health emergency.gov.au/ internet/healthemergency/publishing.nsf/Content/18D06 BAC4644C98DCA25763E00823442/$File/ozflu-no31-2009.pdf. Accessed October 19, 2010.
10. Australian Institute of Health and Welfare. 2010 pandemic vaccination survey summary results August 2010. Available at: http://aihw.gov.au/ publications/phe/128/12096.pdf. Accessed October 19, 2010.
11. Australian Government Department of Health and Aging. Australian Immunisation Handbook 9th Edition 2008. 2008 Available at: http://www.health. gov.au/internet/immunise/publishing.nsf/Content/Handbook-influenza. Accessed June 10, 2010.
12. Kendal AP, Pereira MS, Skehel JJ. Concepts and Procedures for Laboratory-Based Influenza Surveillance. Atlanta, GA: US Department of Health and Human Services, Public Health Service, Centers for Disease Control and Prevention; 1982.
13. Tasker SA, Treanor JJ, Paxton WB, et al. Efficacy of influenza vaccination in HIV-infected persons. A randomized, double-blind, placebo-controlled trial. Ann Intern Med. 1999;131:430-433.
14. Gilbert GL, Cretikos MA, Hueston L, et al. Influenza A (H1N1) 2009 antibodies in residents of new South Wales, Australia, after the first pandemic wave in the 2009 southern hemisphere winter. PLoS ONE. 2010;5:e12562. doi:10.1371/journal.pone.0012562.
15. Chen MI, Lee VJ, Lim W, et al. 2009 influenza A(H1N1) seroconversion rates and risk factors among distinct adult cohorts in Singapore. JAMA. 2010;14:1383-1391.
16. Ross T, Zimmer S, Burke D, et al. Seroprevalence following the second wave of pandemic 2009 H1N1 influenza. PLoS Curr Influenza. 2010; RRN1148. Available at: http://www.ncbi.nlm.nih.gov/pmc/article/PMC2828126/?tool= pmcentrez. Accessed June 4, 2010.
17. Greenberg ME, Lai MH, Hartel GF, et al. Response to a monovalent 2009 influenza A (H1N1) vaccine. N Engl J Med. 2009;361:2405-2413.
18. Hancock K, Veguilla V, Lu X, et al. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med. 2009;361: 1945-1952.
19. Benne CA, Kroon FP, Harmsen M, et al. Comparison of neutralizing and hemagglutination-inhibiting antibody responses to influenza A virus vaccination of human immunodeficiency virus-infected individuals. Clin Diagn Lab Immunol. 1998;5:114-117.
20. Bickel M, Wieters I, Khaykin P, et al. Low rate of seroconversion after vaccination with a split virion, adjuvanted pandemic H1N1 influenza vaccine in HIV-1-infected patients. AIDS. 2010;24:F31-F35.
21. Orlando G, Pariani E, Mazza F, et al. Pandemic influenza vaccine in adult HIV-1-infected patients. AIDS. 2010;24:2142-2143.
22. Bachmann MF, Ecabert B, Kopf M. Influenza virus: a novel method to assess viral and neutralizing antibody titers in vitro. J Immunol Methods. 1999;225:105-111.
23. Fuller JD, Craven DE, Steger KA, et al. Influenza vaccination of human immunodeficiency virus (HIV)-infected adults: impact on plasma levels of HIV Type 1 RNA and determinants of antibody response. Clin Infect Dis. 1998;28:541-547.